176K - views

TUBERCULOSIS WHO Global Tuberculosis Report More than companies are involved in the development of TB diagnostics There are new or re purposed anti TB drugs in late phases of clinical development

In the last two years two new drugs have been approved for the treatment of MDR TB under specific conditions bedaquiline and delamanid There are currently 15 vaccine candidates in clinical trials US billion per year is needed for a full response to

Tags : the last two
Embed :
Pdf Download Link

Download Pdf - The PPT/PDF document "TUBERCULOSIS WHO Global Tuberculosis Rep..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

TUBERCULOSIS WHO Global Tuberculosis Report More than companies are involved in the development of TB diagnostics There are new or re purposed anti TB drugs in late phases of clinical development






Presentation on theme: "TUBERCULOSIS WHO Global Tuberculosis Report More than companies are involved in the development of TB diagnostics There are new or re purposed anti TB drugs in late phases of clinical development"— Presentation transcript: